When.com Web Search

  1. Ads

    related to: alternatives to statins to lower cholesterol side effects doctor

Search results

  1. Results From The WOW.Com Content Network
  2. An alternative to statins may help reduce deaths from heart disease among people with high levels of LDL, or “bad” cholesterol, new research finds.. When taken as a daily pill, bempedoic acid ...

  3. Statins are a popular cholesterol-reducing medication, but come with a risk of muscle aches and other uncomfortable side effects. New research finds that bempedoic acid may be an effective ...

  4. Non-statin cholesterol-lowering drugs may help reduce liver ...

    www.aol.com/non-statin-cholesterol-lowering...

    Out of five non-statin cholesterol-lowering drug classes, only cholesterol absorption inhibitors are found to reduce the risk of liver cancer, a new study has found. The link between liver cancer ...

  5. Alirocumab - Wikipedia

    en.wikipedia.org/wiki/Alirocumab

    In July 2015, the FDA approved alirocumab as a second-line treatment to lower LDL cholesterol for adults who have hereditary high cholesterol and people with atherosclerosis who require additional lowering of LDL cholesterol when diet and statin treatment have not worked. [7] This was the first approval of a PCSK9 inhibitor. [7]

  6. Lipid-lowering agent - Wikipedia

    en.wikipedia.org/wiki/Lipid-lowering_agent

    Level of the good cholesterol HDL is also increased. Fibrates may decrease LDL, though generally to a lesser degree than statins. Similar to statins, the risk of muscle damage exists. Nicotinic acid, like fibrates, is also well suited for lowering triglycerides by 20–50%. It may also lower LDL by 5–25% and increase HDL by 15–35%.

  7. Fenofibrate - Wikipedia

    en.wikipedia.org/wiki/Fenofibrate

    Fenofibrate (sold under the brand name Tricor among others), is an oral medication of the fibrate class used to treat abnormal blood lipid levels. [3] It is less commonly used compared to statins because it treats a different type of cholesterol abnormality to statins.